Dr. Harald Poth was member of the managing board of LBBW VC until February 2023 and headed the Life Science Team. He gained over 20 years investment experience in that field. Recent successful exits were Ganymed Pharmaceuticals GmbH, sloning biotechnology GmbH, Proabiogen Ag and mtm diagnostics. Prior to his VC activities he headed the Life Science startup agency in Baden-Württemberg. He studied Biology at the University Hohenheim in Stuttgart, holds a PhD with distinction in Microbiology from Hohenheim and gained scientific experience at the Université de Genève, the University of Pennsylvania, and the Biotechnology Research Centre in Braunschweig. Dr. Poth will continue to act as advisor to LBBW VC.